MUC5AC and pseudomyxoma peritonei: The activity of these two substances, alone or in combination, was extensively analyzed in the context of mucin-producing gastrointestinal cancer cell lines, mucinous ascites from PMP patients and preclinical models of PMP and PMCA [73,74].